EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer

Yong-Nan Chi, Chen-Yang Wang, Tao Yang, Ying Liu, Deng-Long Wu, Sheng-Song Huang

Asian Journal of Andrology · 2026-11 · 28 (6) · 879-885

DOI: 10.4103/aja202632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 01.09.2026. Verfasst von Yong-Nan Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China. Hauptthemen laut MEDLINE: Genistein, Receptors, Androgen, Prostatic Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgens and the androgen receptor ( AR ) play a central role in the development and progression of prostate cancer. While biochanin A (BCA) has been reported to suppress androgen synthesis and overcome resistance to abiraterone and enzalutamide, its direct effects on AR , particularly mutant AR , remain unclear. In this study, we systematically investigated the binding affinity and functional impact of BCA on a panel of clinically relevant AR mutations to identify patient subgroups that may benefit from BCA treatment. Our results demonstrated that BCA exhibits high-binding affinity toward the ART877A and ARW741C mutants. Our findings reveal a previously unrecognized mechanism by which BCA directly targets specific AR mutants, in addition to inhibiting androgen biosynthesis. This study provides mechanistic insights into the mutation-selective activity of BCA and supports its potential clinical application in molecularly stratified prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenisteinReceptors, AndrogenProstatic NeoplasmsMaleHumansMutationCell Line, Tumor

Stichwörter der Autor:innen

androgen receptor mutationbiochanin Aprostate cancer

Substanzen

Genisteinbiochanin AReceptors, AndrogenAR protein, human

Autor:innen und Institutionen

  • Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
  • Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.

Zitieren

APA

Chi, Y. N., Wang, C. Y., Yang, T., Liu, Y., Wu, D. L., & Huang, S. S. (2026). Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer. Asian Journal of Andrology, 28(6), 879-885. https://doi.org/10.4103/aja202632

Vancouver

Chi YN, Wang CY, Yang T, Liu Y, Wu DL, Huang SS. Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer. Asian Journal of Andrology. 2026;28(6):879-885. doi:10.4103/aja202632

BibTeX
@article{Chi2026,
  author = {Chi, Yong-Nan and Wang, Chen-Yang and Yang, Tao and Liu, Ying and Wu, Deng-Long and Huang, Sheng-Song},
  title = {Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer},
  journal = {Asian Journal of Andrology},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {879--885},
  doi = {10.4103/aja202632}
}
Kostenlos starten →